Breaking News! German Study Finds That SARS-CoV-2 Aggressively Kills Human Hepatocytes and Damages Liver Tissues

Medical News: Shocking Discovery on Liver Impacts of SARS-CoV-2
In a groundbreaking revelation, a team of German researchers has uncovered a chilling new dimension of the havoc wreaked by SARS-CoV-2, the virus responsible for COVID-19. The study reveals that the virus not only targets respiratory systems but also aggressively invades and kills human hepatocytes - the main cells of the liver. This discovery sheds light on a new pathway for organ damage, emphasizing the extensive reach of this deadly virus.


German Study Finds That SARS-CoV-2 Aggressively Kills Human Hepatocytes and Damages Liver Tissues

The research, spearheaded by scientists from the Technical University of Munich, Helmholtz Munich, Hannover Medical School, and other prestigious German institutions, has provided evidence that SARS-CoV-2 directly infects liver cells, causing replication-dependent cell death.
 
The Scope of the Study
This Medical News report highlights how the research team conducted meticulous investigations into the interactions between SARS-CoV-2 and liver cells. The researchers utilized primary human hepatocytes (PHH), hepatoma cell lines, and a mouse model to explore how the virus invades liver cells and the subsequent outcomes. They found that hepatocytes express the ACE2 receptor and TMPRSS2 protease - key entry points for the virus. When these were blocked or knocked down, the ability of SARS-CoV-2 to infect the cells was drastically reduced.
 
The scientists also reported a dramatic rise in liver enzyme levels in infected subjects, indicating severe liver injury. "This finding strongly suggests that SARS-CoV-2 is not merely a bystander in liver dysfunction but an active perpetrator," noted Dr. Ulrike Protzer, one of the lead authors.
 
Key Findings in Detail
-Mechanism of Infection
The study confirmed that SARS-CoV-2 employs its spike protein to bind to ACE2 receptors on hepatocytes, enabling the virus to enter these cells. Once inside, the virus hijacks the cell machinery to replicate and spread. The infected hepatocytes not only die as a result but also release infectious viral particles that can continue the cycle.
 
To confirm these mechanisms, researchers used specific RNA interference techniques to knock down ACE2 and TMPRSS2 expression in hepatocytes. The results showed a dramatic reduction in viral entry, proving that these two proteins are essential for the infection process. This finding opens new avenues for developing targeted treatments that block these pathways.
 
-Extent of Liver Damage
Histological analysis of liver tissues in infected mice revealed extensive damage, including immune cell infiltration, tissue death, and inflammation. Elevated levels of alanine aminotransferase (ALT), a marker of liver damage, were observed during peak viral replication. These observations suggest that the virus’s replication directly causes hepatocyte death, while the immu ne system’s response to clear the virus exacerbates the damage.
 
Researchers also noted the appearance of coronavirus-like particles within liver cells under electron microscopy, providing direct evidence of viral replication. These findings indicate that SARS-CoV-2’s impact on the liver is not limited to secondary effects but involves direct cytopathic effects as well.
 
-Variant-Specific Impacts
Interestingly, the study compared the effects of different SARS-CoV-2 variants, including the ancestral strain, Delta, and Omicron. While the Omicron variant caused faster cell death, the extent of damage was less severe compared to other variants. This suggests that different viral strains may have varying tropisms and pathogenic potentials in liver tissue. Omicron’s rapid replication but lower cytopathic effect may partially explain its clinical behavior, where it causes widespread infection with generally less severe outcomes in some tissues. The fact that all variants have the ability to compromise vital organs remains concerning.
 
-Mouse Model Corroboration
In a mouse-adapted model, SARS-CoV-2 was found to infect the liver, corroborating findings in human cell cultures. The researchers observed marked elevations in inflammatory markers like interleukin-6 (IL-6), which likely contribute to the systemic hyperinflammation seen in severe COVID-19 cases. Furthermore, liver tissue samples showed significant immune cell infiltration, suggesting that both direct viral effects and immune-mediated damage play roles in liver pathology.
 
Histological evidence from the mouse model showed that SARS-CoV-2 targets not just hepatocytes but also cholangiocytes - cells lining the bile ducts. This broad targeting further complicates the virus’s impact on liver function.
 
Broader Implications for Patients
These findings have profound implications for COVID-19 patients, especially those with pre-existing liver conditions. Patients with liver cirrhosis or other chronic liver diseases were already known to have higher mortality rates when infected with SARS-CoV-2. This study provides a mechanistic explanation, demonstrating that the virus’s direct cytopathic effects on hepatocytes, combined with immune-mediated damage, create a double assault on liver health.
 
Dr. Chunkyu Ko, one of the co-lead authors, emphasized, "The liver is a central organ for detoxification and metabolic regulation. Damage to the liver can have cascading effects on a patient’s overall health, making these findings particularly concerning."
 
Clinical Recommendations and Future Research
The study emphasizes the need for clinicians to closely monitor liver function in COVID-19 patients. Routine liver enzyme tests could help detect early signs of hepatic involvement, enabling timely interventions. Moreover, targeted antiviral therapies that inhibit SARS-CoV-2 replication may also protect the liver from extensive damage.
 
Future research is essential to uncover the precise pathways of cell death triggered by SARS-CoV-2 in liver tissues. This could lead to the development of therapeutic strategies that mitigate liver damage without compromising the body’s ability to clear the virus. Additionally, further studies should investigate the long-term consequences of liver involvement in COVID-19 survivors, particularly those with pre-existing conditions.
 
Conclusions
The groundbreaking study by German researchers underscores the liver’s vulnerability to SARS-CoV-2. By directly infecting hepatocytes and triggering cell death, the virus inflicts significant damage, contributing to the elevated liver enzyme levels and poor outcomes observed in many COVID-19 patients. The discovery of ACE2 and TMPRSS2 as critical enablers of viral entry into liver cells opens up new avenues for therapeutic interventions. Additionally, the differences in damage caused by various SARS-CoV-2 variants hint at the evolving challenges posed by this pandemic.
 
While the study highlights the alarming extent of liver damage, it also provides hope. Understanding these mechanisms enables the medical community to develop strategies to mitigate such damage and improve outcomes for COVID-19 patients worldwide. As we continue to battle this global health crisis, research like this serves as a reminder of the virus's wide-reaching impact and the importance of a comprehensive approach to tackling it.
 
Acknowledgments
The study was conducted with contributions from multiple institutions, including the Technical University of Munich, Helmholtz Munich, Hannover Medical School, and the German Center for Infection Research. Funding was provided by the German Research Foundation, the European Commission, and the Federal Ministry of Education and Research, among others.
 
The study findings were published in the peer-reviewed Journal of Medical Virology.
https://onlinelibrary.wiley.com/doi/10.1002/jmv.70156
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/breaking-study-finds-that-covid-19-accelerates-liver-cancer-growth-and-spread-via-exosomes-derived-from-syncytia
 
https://www.thailandmedical.news/news/sars-cov-2-spike-protein-interacts-with-12-liver-proteins-reactivates-hbv-and-activates-pre-cancerous-pathways
 
https://www.thailandmedical.news/news/covid-19-induced-long-term-liver-injury-uncovered-by-ultrasound-technology
 
https://www.thailandmedical.news/news/covid-19-worsens-existing-liver-disease-and-could-spur-liver-cancer-development
 
https://www.thailandmedical.news/news/singapore-case-study-reveals-that-even-mild-covid-19-can-trigger-fatal-liver-failure-in-patients-with-autoimmune-liver-disease
 
https://www.thailandmedical.news/news/liver-stress-detected-in-mild-and-asymptomatic-omicron-cases
 
https://www.thailandmedical.news/news/liver-function-abnormalities-linked-to-long-covid-digestive-issues
 
https://www.thailandmedical.news/news/study-reveals-that-covid-19-is-causing-the-new-onset-of-acute-and-chronic-liver-disease-in-many
 
https://www.thailandmedical.news/news/thailand-led-medical-study-finds-that-liver-cancer-is-now-a-major-health-issue-in-the-asia-pacific-region
 
https://www.thailandmedical.news/news/new-study-findings-reveal-long-term-risks-of-liver-issues-from-covid-19
 
https://www.thailandmedical.news/news/covid-19-news-scientists-unveil-molecular-mechanisms-underlying-sars-cov-2-hepatotropism-and-liver-damage
 
https://www.thailandmedical.news/news/breaking-international-study-warns-that-pfizer-s-mrna-vaccines-could-be-causing-a-silent-pandemic-of-liver-injury
 
https://www.thailandmedical.news/news/breaking-news-brazilian-study-shockingly-finds-that-sars-cov-2-directly-infects-liver-cells-or-hepatocytes-to-cause-hyperglycemia
 
https://www.thailandmedical.news/news/new-york-clinicians-sound-the-alarm-covid-19-asymptomatic-individuals-can-suffer-acute-liver-injury
 
https://www.thailandmedical.news/news/covid-19-research-the-detrimental-effects-of-tnf%CE%B1-on-liver-during-sars-cov-2-infection-and-its-impact-on-patient-survival
 
https://www.thailandmedical.news/news/breaking-covid-19-news-brazil-study-shows-that-most-long-covid-individuals-continue-to-sustain-damaged-liver-functions-up-to-20-months
 
https://www.thailandmedical.news/news/breaking-covid-19-news-sars-cov-2-that-causes-liver-impairment-in-many-also-cause-hypoalbuminemia
 
https://www.thailandmedical.news/news/breaking-study-finds-that-upregulated-interleukin-6-drives-development-of-rare-liver-cancers-covid-19-infections-causes-elevated-il-6-levels-in-many
 
https://www.thailandmedical.news/news/researchers-alarmingly-find-that-metabolic-associated-fatty-liver-disease-mafld-may-be-a-prevalent-long-covid-manifestation
 
https://www.thailandmedical.news/news/breaking-sars-cov-2-infection-induces-increase-of-gp73-that-causes-dysglycaemia-increased-gp73-could-also-imply-future-liver-disease-and-liver-cancer
 
https://www.thailandmedical.news/news/belgium-researchers-warn-that-more-hospitalized-covid-19-patients-are-manifesting-a-rare-chronic-liver-disease-known-as-sclerosing-cholangitis-could-b
 
https://www.thailandmedical.news/news/coronavirus-news-german-study-confirms-that-sars-cov-2-coronavirus-can-invade-and-damage-the-liver
 
https://www.thailandmedical.news/news/fatty-liver-disease-increases-risk-of-covid-19-hospitalization-but-majority-do-not-even-know-they-have-fatty-liver-disease
 
https://www.thailandmedical.news/news/covid-19-news-studies-warn-that-individuals-with-liver-cirrhosis-likely-to-die-upon-contracting-covid-19
 
https://www.thailandmedical.news/news/breaking-covid-19-research-studies-warn-of-high-prevalence-of-liver-injury-in-covid-19-patients
 
https://www.thailandmedical.news/news/covid-19-research-university-of-bristol-researchers-warn-that-liver-complications-are-common-in-covid-19-patients